AI Article Synopsis

  • Drug repositioning involves finding new uses for existing drugs and is gaining traction as a promising strategy in drug development.
  • The paper introduces DrPOCS, a new method that uses low-rank matrix formulation and combines drug structure with disease data to predict associations between old drugs and diseases through matrix completion.
  • DrPOCS shows superior accuracy compared to existing methods and successfully predicts novel drug indications, which are supported by various forms of evidence.

Article Abstract

Drug repositioning, i.e., identifying new indications for known drugs, has attracted a lot of attentions recently and is becoming an effective strategy in drug development. In literature, several computational approaches have been proposed to identify potential indications of old drugs based on various types of data sources. In this paper, by formulating the drug-disease associations as a low-rank matrix, we propose a novel method, namely DrPOCS, to identify candidate indications of old drugs based on projection onto convex sets (POCS). With the integration of drug structure and disease phenotype information, DrPOCS predicts potential associations between drugs and diseases with matrix completion. Benchmarking results demonstrate that our proposed approach outperforms popular existing approaches with high accuracy. In addition, a number of novel predicted indications are validated with various types of evidences, indicating the predictive power of our proposed approach.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCBB.2018.2830384DOI Listing

Publication Analysis

Top Keywords

indications drugs
12
drug repositioning
8
based projection
8
projection convex
8
convex sets
8
drugs based
8
proposed approach
8
drpocs drug
4
repositioning based
4
sets drug
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!